AMI Cardiogenic Shock
Early Stabilization Can Improve Outcomes in Cardiogenic Shock
Impella® heart pumps have the ability to stabilize patient hemodynamics, unload the left ventricle, perfuse end organs, and allow for recovery of the native heart in patients with ongoing cardiogenic shock. Identifying patients early, treating them with a proven protocol, and following them with hemodynamic monitoring and aggressive down titration of inotropes and vasopressors can reverse the downward spiral of cardiogenic shock and help patients achieve myocardial recovery.
Resources for Health Care Professionals
DanGer Shock Randomized Controlled Trial (RCT) Confirms Routine Use of Impella CP® Heart Pump Improves Survival in Heart Attack with Shock
This investigator-initiated study is the first RCT of Impella in cardiogenic shock (CS), assessed the efficacy of Impella CP® with or without SmartAssist® heart pumps in treating patients with AMIC shock with STEMI, undergoing emergency PCI.
Successful Mechanical Circulatory Support (MCS) in Cardiogenic Shock Patients - Clinical Best Practices
Successful Mechanical Circulatory Support (MCS) in Cardiogenic Shock Patients - An Overview
These articles highlight the ongoing need for overarching guidelines on patient care decisions for cardiogenic shock. Get an overview about the publications in the European Heart Journal Supplements.
European Heart Journal Supplements Cardiogenic Shock - Glimpse into the Future
This article examines current evidence for the use of mechanical circulatory support (MCS) in cardiogenic shock and discusses how the scientific community can advance research in this area.
Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Watch the interview with Dr. Pappalardo and learn more about ICU Management of patients requiring hemodynamic support.
NPS-2633